Navigation Links
Selective Insurance Group Announces Officer Appointments
Date:12/4/2007

esident and claim group general counsel for St. Paul Travelers. She is a graduate of C.W. Post College, Long Island University and the National Law Center, George Washington University, Washington, D.C. Ms. Porter is also a member of the Defense Research Institute (DRI), ARIAS (AIDA Reinsurance and Insurance Arbitration Society) and a former member of the District of Columbia Defense Lawyers Association (President - 1991).

Eduard J. Pulkstenis (Lafayette, NJ), to executive vice president and chief underwriting officer. Mr. Pulkstenis joined Selective's Actuarial Department in 1988 and in 2000 became vice president and manager of the company's Actuarial Pricing unit. He assumed leadership for the Commercial Lines Small Business unit in 2003, and in 2004 was promoted to senior vice president and chief commercial lines underwriting officer. Mr. Pulkstenis was previously a managing actuary at AIG. Mr. Pulkstenis is a graduate of Messiah College. He is a Fellow of the Casualty Actuarial Society, a member of the American Academy of Actuaries and holds the Chartered Property Casualty Underwriter (CPCU) designation.

Selective Insurance Group, Inc. is a holding company for seven property and casualty insurance companies rated A+ (Superior) by A.M. Best. Through independent agents, the insurance companies offer primary and alternative market insurance for commercial and personal risks, and flood insurance underwritten by the National Flood Insurance Program. Other subsidiaries of the company provide claims, human resources and risk management services. Selective maintains a website at http://www.selective.com.


'/>"/>
SOURCE Selective Insurance Group, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Novel 3-D cell culture model shows selective tumour uptake of nanoparticles
2. Selective attention increases both gain and feature selectivity of the human auditory cortex
3. Pharmacopeia Acquires Selective Androgen Receptor Modulator (SARM) Program from Bristol-Myers Squibb
4. SGX Pharmaceuticals Submits Investigational New Drug Application for SGX523, a Highly Potent, Selective, Orally Bioavailable cMET Inhibitor
5. Patients with Medicaid and those lacking insurance have higher risk of advanced laryngeal cancer
6. Insurance Impacts Laryngeal Cancer Detection
7. Record Number of Americans Lack Health Insurance
8. National Association of Subrogation Professionals (NASP), the Largest Insurance Subrogation Association in the World - Announced Today that Leslie Wiernik has Joined the Organization as Director of Education
9. CIGNA Group Insurance Shows Consumers Theres More to Life Through a New Consumer Education Toolkit
10. HealthInsuranceFinders.com Launches Video Contest for Young Directors
11. Dr. Allen Woolf Appointed Chief Medical Officer For CIGNA Group Insurance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2008)...July 9 /PRNewswire/ -- leViv, Inc. (http://www.le... nutrition and lifestyle programs for,individual h.... The new,programs include 28-days of delicious, d...r 110 items in every order), online recipes, healt...urces, professional advice,news, health informati...
(Date:7/9/2008)... /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE...s to the global life,sciences markets, today annou...mited (AECL) with notice of arbitration proceeding...fulfill its contractual obligations,under its 2006...d if not,granted, seeking significant monetary dam...
(Date:7/9/2008)... adds to its unparalleled content on breastfeeding... professional articles on child, health, from alle...lking., BOULDER, Colo., July 9 /PRNewswire/ -- Br...verything for the New Mom, improves its already,un... doctor-reviewed,professional articles on infant, ...
(Date:7/9/2008)... DRE, Inc., a premier international surgical...mers that as much as $250,000 in medical equipment...lings. , Louisville, KY (...f 2008, in accordance with Tax Code Section 179, c...t bought in 2008. This could make 2008 an attracti...
Breaking Medicine News(10 mins):Health News:leViv Launches First Meal Programs Specifically Designed for Taste and Health 2Health News:leViv Launches First Meal Programs Specifically Designed for Taste and Health 3Health News:MDS Commences Arbitration against AECL over Cancelled MAPLE Project and Files $1.6 Billion Court Claim against AECL and the Government of Canada 2Health News:MDS Commences Arbitration against AECL over Cancelled MAPLE Project and Files $1.6 Billion Court Claim against AECL and the Government of Canada 3Health News:Breastfeeding.com Becomes a Premier Resource on Child Health 2Health News:Economic Stimulus Act Can Improve Medical Equipment Purchasing Power 2
... in more than a year has highlighted growing compl...mains endemic in the country, experts said Sunday ...he capital Hanoi was killed by the H5N1 strain a w... more people are known to have been infected with ...
...rn after embryo biopsy for preimplantation genetic...mations than those born after artificial reproduct... option for couples at risk of transmitting geneti...a prenatal diagnosis followed by a termination of ...
...wo minutes to cut the umbilical cord after birth, ... reduces the risk of blood disorders . The study ... Hamilton, Canada, and involved more than 1,900 ne...ssistant dean of midwifery at the university, said...
...fied potential chinks in the parasite that causes ...isease that afflicts some 12 million people around...protozoa that cause most cases of leishmaniasis co...ackling this neglected disease are already slender...
Other Medicine News:Health News:Vietnam Bird Flu Death a Call for Action, Say Experts 2Health News:Vietnam Bird Flu Death a Call for Action, Say Experts 3Health News:Children Born After PGD as Healthy as Kids Born After ART 2Health News:2 Minute Delay in Cutting Cord can Give Babies a 'significant' Health Boost 2Health News:Gene Study Throws Up New Targets for Leishmaniasis 2
(Date:7/6/2008)... BD GeneOhm(TM) Cdiff Assay Submitted for F...Call/ -- BD Diagnostics, a segment,of BD (Becton, ...day the CE,marking of the BD GeneOhm(TM) Cdiff mol...ith Clostridium difficile infection (CDI). It is t...ty, simplicity and speed in one test,procedure. BD...
(Date:7/3/2008)... SAN FRANCISCO, July 3 /- M...hat it will hold a teleconference at 5:00,p.m. EDT...om its,randomized, double-blind, placebo-controlle...ton,s disease., Teleconference/Webcast Details, ... at 5:00 p.m. Eastern,time by telephone, please di...
(Date:7/3/2008)... NEW BRUNSWICK, N.J., July 3 /PRNewswire-FirstCall..."Company") (Amex: SNT ) announced today,that it h...("VGXI") to,supply the plasmid portion of the Comp... 5A gene and siRNA against Factor 5A., Senesco ha... results,using its combination siRNA and plasmid a...
(Date:7/2/2008)... - Top-line Data Expected in Augus... Isolagen(TM), Inc. (Amex:,ILE) announced today th...s,Phase III clinical studies (IT-R-005/006) invest... of nasolabial folds, or wrinkles. The last,person...follow-up visit,and collation of this data has be...
Breaking Medicine Technology:BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections 2BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections 3Medivation to Host Conference Call at 5 p.m. EDT Monday to Discuss Top-Line Phase 2 Study Results in Huntington's Disease 2Senesco Chooses VGXI to Produce Factor 5A Plasmid 2Senesco Chooses VGXI to Produce Factor 5A Plasmid 3Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles 2Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles 3Nabi Biopharmaceuticals Announces Successful Completion of NicVAX 28R 29 Phase 2b Trial 3B Drug Shows Statistically Significant Rates of Smoking Cessa 789 1Nabi Biopharmaceuticals Announces Successful Completion of NicVAX 28R 29 Phase 2b Trial 3B Drug Shows Statistically Significant Rates of Smoking Cessa 789 2Nabi Biopharmaceuticals Announces Successful Completion of NicVAX 28R 29 Phase 2b Trial 3B Drug Shows Statistically Significant Rates of Smoking Cessa 789 3Nabi Biopharmaceuticals Announces Successful Completion of NicVAX 28R 29 Phase 2b Trial 3B Drug Shows Statistically Significant Rates of Smoking Cessa 789 4Nabi Biopharmaceuticals Announces Successful Completion of NicVAX 28R 29 Phase 2b Trial 3B Drug Shows Statistically Significant Rates of Smoking Cessa 789 5Nabi Biopharmaceuticals Announces Successful Completion of NicVAX 28R 29 Phase 2b Trial 3B Drug Shows Statistically Significant Rates of Smoking Cessa 789 6Nabi Biopharmaceuticals Announces Successful Completion of NicVAX 28R 29 Phase 2b Trial 3B Drug Shows Statistically Significant Rates of Smoking Cessa 789 7Mexicos expanded health insurance improves hypertension treatment 5750 1Mexicos expanded health insurance improves hypertension treatment 5750 2New research to help fight widespread potato disease 1140 1New research to help fight widespread potato disease 1140 2Pollution from marine vessels linked to heart and lung disease 1137 1Pollution from marine vessels linked to heart and lung disease 1137 2
...evention of Cervical Cancer and Other Human,Papill... of Follow,Up in Large Phase III Clinical Studies ...nd Journal of Medicine publishes the most comprehe...lomavirus vaccine , LYON, France, 10th May2007 &nd...nd sustained efficacy of Gardasil® in the,prev...
... Germany, May 10th, 2007 - Antisense,Pharma today ...minary Results of a Phase I/II-Study in Pancreatic...cinoma with the,TGF-beta2 Inhibitor AP 12009&rdquo... 43rd Annual Meeting of the American Society of,Cl...ago, Illinois,U.S.A, from June 1st - 5th. , In th...
Other Medicine Technology:Gardasil Demonstrates Up to 100% Efficacy 2Gardasil Demonstrates Up to 100% Efficacy 3Gardasil Demonstrates Up to 100% Efficacy 4Gardasil Demonstrates Up to 100% Efficacy 5Gardasil Demonstrates Up to 100% Efficacy 6Gardasil Demonstrates Up to 100% Efficacy 7Phase I/II-data on Systemic Application of the TGF-beta2-inhibitor,AP 12009 to be Presented 2
The ProtecPoint Exit Alerting System, instantly help protect individuals (e.g. patients, staff) and assets (e.g. medical equipment), with easily-mountable exit controllers placed throughout your faci
...nt of controlled substances, critical supplies, or...vess" are designed to perform this function. Conti...ervention. Radio frequency identification (RFID) t...lf™ product solutions incorporate custom desi...
Agility can facilitate bed and room management through business process optimization using RFID technology. Bed and room management may be integrated with other AgileTrac products.
Assetrac allows identification, location, and protection of your assets.
Medicine Products: